Calcineurin signaling is essential for successful muscle regeneration. Although calcineurin inhibition compromises muscle repair, it is not known whether calcineurin activation can enhance muscle repair after injury. Tibialis anterior (TA) muscles from adult wild-type (WT) and transgenic mice overexpressing the constitutively active calcineurin-A transgene under the control of the mitochondrial creatine kinase promoter (MCK-CnA * ) were injected with the myotoxic snake venom Notexin to destroy all muscle fibers. The TA muscle of the contralateral limb served as the uninjured control.
Introduction
Calcineurin is a serine-threonine phosphatase enzyme which regulates transcription by sensing changes in intracellular calcium-calmodulin concentrations (32) .
The calcineurin signal transduction pathway is important in skeletal muscle biology, as it can regulate the slow oxidative phenotype, regeneration, and myofiber growth (11, 16, 29) . In animal models, pharmacological inhibition of calcineurin impairs skeletal muscle regeneration after injury (1; 38) and in regenerating muscles of young, mdx dystrophic mice it can severely compromise muscle structure and function (44). The effect of calcineurin stimulation on muscle regeneration efficacy is unknown.
Calcineurin controls satellite cell differentiation and myofiber growth and maturation. Activated calcineurin promotes the transcription and activation of myoregulatory factors, MEF2, myogenin, and MyoD, either directly or in conjunction with NFAT (6, 11, 12, 38) . The NFATc1, -c2, and -c3 isoforms are expressed in skeletal muscle (15) and have been observed in the cytoplasm of muscle cells at all stages of development (1) . Specificity may exist among the NFAT isoforms in gene regulation, as each isoform has been shown to translocate to the nucleus at specific stages of muscle differentiation (1) . Myogenin, MyoD, and MEF2 stimulate the differentiation of satellite cells and maturation of myoblasts into myotubes (30) . MEF2a also regulates the expression of the developmental MyHC isoform in newly regenerated fibers (35) and slow fiber type specific genes (49) . In maturing muscle fibers, calcineurin can alter the expression of adult type I and IIa MyHC isoforms (2, 48) Calcineurin has been implicated in regulating myofiber growth and a positive relationship between calcineurin activation and muscle hypertrophy has been demonstrated (25) . In myocyte cultures, calcineurin activation enhanced myotube formation (5) . Cells expressing the CnA * transgene were larger, contained more myonuclei, and MyHC protein and the hypertrophic response was associated with increased NFATc3 nuclear translocation (5) . In vitro, IGF-I has been shown to activate calcineurin and its downstream transcription factors NFATc1 and GATA to stimulate myocyte hypertrophy (28, 42) . Pharmacological inhibition of calcineurin prevented hypertrophy following functional overload of mouse plantaris muscle (9, 10) . However, in vitro the contribution of calcineurin signalling to muscle hypertrophy is influenced by experimental design (41) . In experiments where the hypertrophic response depended on myoblast maturation and fusion (42) or the addition of myonuclei (26), the involvement of the calcineurin signal transduction pathway appears more definite. During development, myoblasts fuse to form nascent myotubes with a limited number of myonuclei. Further growth of these nascent myofibers depends on the fusion of additional myonuclei (16) , and this can be controlled by calcineurin and NFATc2 (19) .
Activation and nuclear translocation of NFATc2 in nascent myotubes stimulates IL-4 transcription and synthesis (18) . Secreted IL-4 is thought to bind to its receptor on myoblasts to initiate fusion of myoblasts to nascent myotubes (18) . The physiological significance of this pathway has been demonstrated in cell cultures and NFATc2 -/-knockout mice (16, 17, 19) . In vivo, NFATc3 may also regulate early events in primary myogenesis, as muscles from NFATc3 -/-knockout mice contain fewer myofibres than WT mice, however, mean fibre size is normal in these mice (21) .
It is important to note that the effect of calcineurin activation on growth and hypertrophy is strongly influenced by muscle phenotype. Compared with wild type mice, slow-twitch muscles (e.g. soleus) of mice over-expressing an activated form of calcineurin (MCK-CnA * ) have greater mass and their mean fiber cross-sectional area is greater (47). However, fast-twitch muscles (e.g. TA and medial gastrocnemius) of MCK-CnA * mice have a smaller mass and fiber size compared with muscles from wild type mice, and there is no change in mass or fiber size of muscles with an intermediate phenotype (e.g. plantaris) (47). Furthermore, genetic inhibition of calcineurin by muscle specific over-expression of MCIP1 reduced fiber size by in slow-twitch soleus muscles by 30%, but had no effect on fiber size in any other muscle type (31) .
The aim of this study was to investigate whether expression of the constitutively active CnA * transgene would improve muscle structure and function in regenerating muscles after myotoxic injury. It was hypothesized that increased calcineurin activity would hasten muscle regeneration by stimulating satellite cell differentiation and fusion of differentiated satellite cells to nascent myofibers, accelerating recovery of myofiber size. Furthermore, it was hypothesized that calcineurin activation would stimulate the maturation of newly regenerated myofibers, thus enhancing functional recovery.
Methods

Transgenic Mice
All experiments were approved by the Animal Experimentation Ethics Committee 
Experimental Injury
Muscle regeneration was assessed at 5 days and 9 days post-injury. In the 5 days post-injury group, the right TA was injured and the left TA muscle served as the uninjured control for assessment of muscle structure and function. In the 9 days postinjury group, the left TA muscle was injured and used for muscle function testing and the right TA muscle served as the uninjured control. Histological and immunohistochemical analysis was performed on the injured and uninjured muscles at 5 and 9 days post-injury.
We have shown previously that after Notexin damage, muscle function can be measured reliably at 7 days post-injury (40) . Before this time, the structural integrity of the degenerating-regenerating muscle does not permit consistent and reliable assessments of force producing capacity. Mice were anesthetized with 100 mg·kg Michel clips (Aesculap, Tuttlingen, Germany) and the mice were kept warm on a heat pad and monitored closely until they regained consciousness. Injecting a muscle with Notexin destroys all mature muscle fibers, but leaves satellite cells intact to facilitate muscle regeneration (14) . The contralateral uninjured TA muscle was not injected with a saline vehicle, since previous studies have shown that injecting muscles with saline does not affect muscle function or structure (13, 20, 36) .
Assessment of Muscle Function in situ
Details regarding the in situ TA muscle preparation and measurement of contractile properties have been described previously (7, 40) . Briefly, the anesthetized mouse was placed on a heated (37°C) platform, the left foot of the mouse was secured to the platform and the left knee was secured by pushing a sharpened pin attached to a clamp through the knee joint. The distal portion of the muscle and its tendon were dissected free and maintained at 37°C by incubating the exposed muscle in warmed mineral oil. The tendon was tied with 4-0 braided surgical silk to the lever arm of a dual mode servomotor/force transducer (305-LR; Aurora Scientific Inc.; Ontario, Canada).
The muscle was stimulated maximally by directly applying supramaximal square wave pulses, 10V, 300 ms in duration, to the exposed nerve (40) . Optimum muscle length (L o ) was determined from micromanipulations of muscle length and a series of isometric twitch contractions. Maximum isometric tetanic force (P o ) production was determined from the plateau of the frequency-force relationship. To assess fatigability, P o was determined once every 5 s for 4 min and the muscle was then rested (no stimulation).
Recovery of P o was determined at 1, 2, and 3 min after the fatigue protocol. Optimal fiber length L f was determined by multiplying L o by the TA L f /L o ratio of 0.6 (7).
Following the final evaluation of P o , the TA muscle was carefully dissected from the mouse, trimmed of tendon and suture, and weighed on an analytical balance. The contralateral TA muscle was also excised. Both muscles were mounted separately in embedding medium, frozen in thawing isopentane, and stored at -80ºC for later histological and immunohistochemical analyses. 
Histology and immunohistochemistry
Four 5 Om thick sections were cut from the mid-belly region of each muscle on a cryostat at -20 ºC. The sections were air dried overnight and stored at -80ºC. One section was stained with hematoxylin and eosin (H&E) for determination of fiber crosssectional area, muscle degeneration, and the proportion of centrally nucleated fibers, and the others were used for immunohistochemical analysis. Colored, digitized images of H&E stained sections were captured with a digital camera (Spot, v2. Visualization of developmental MyHC staining on mouse muscle cross-sections was achieved using a peroxidase detection system (Vectastain ABC Kit, #PK-6100, Vector Laboratories) and the AEC+ substrate chromogen (#K3468, Dako Corporation, Botany, Australia) for color development. To control for non-specific staining due to secondary antibody cross-reactivity, one negative control section from WT uninjured muscles incubated with the secondary antibody and the Vectastain kit and another negative control incubated with the Vectastain kit only were included with each staining run. In uninjured muscle sections from WT mice, non-specific staining was minimal and confined to the intersititium and not the myofiber. At 5 days post-injury, there was still a considerable inflammatory response with infiltration of neutrophils and macrophages to remove necrotic myofibers and promote regeneration. This was associated with increased IgG levels in the regenerating muscle and greater non-specific staining in the interstitium making it difficult to discern myoblast and regenerating fibers from inflammatory cells and cellular debris exposed to mouse IgGs. All sections for immunohistochemical analysis were counter stained with hematoxylin which stained nuclei blue.
Statistics
Values presented in all figures and tables are expressed as means ± S.E.M. All statistical analyses were performed using a statistics software package (Minitab Inc., State College, PA). ANOVA or two sample t-tests were used to assess differences between uninjured and 5 or 9 days post-injury TA muscles from MCK-CnA * and WT mice. Tukey's post hoc test was used to locate pair-wise significant differences, where appropriate. For all comparisons, P < 0.05 was considered significant.
RESULTS
Body and muscle mass of MCK-CnA * mice
Body mass was similar in MCK-CnA * and WT mice. TA muscles from MCKCnA * mice had a lower mass than those from WT mice (P < 0.05) and the muscle mass to body mass ratio (MM:BM) was lower (P < 0.05). Nine days after myotoxic injury, muscle mass from both strains was ~30% less than that of uninjured muscles and of injured muscles at 5 days post-injury (P < 0.05; Table 1 ).
Muscle function is improved after injury in MCK-CnA * mice
Twitch force (P t ) tended to be greater (~5%) in uninjured muscles from MCKCnA * than WT mice (P = 0.055). Nine days post injury, P t was ~35% that of uninjured P t (P < 0.05). Maximum isometric force (P o ) was ~20% lower in uninjured muscles from MCK-CnA * than in WT mice (P < 0.05; main effect). Nine days post injury, P o was reduced by 71% compared with uninjured P o in MCK-CnA * and WT mice (P < 0.05).
Normalized force (sP o ) of uninjured muscles from MCK-CnA * mice was ~15% less than that of WT mice (P < 0.05). However, 9 days after injury sP o of muscles from MCK-CnA * and WT mice was similar; 44% and 35% of uninjured sP o , respectively (Table 1 ). Time to peak tension (TPT) and ½ relaxation time (½RT) were prolonged in injured muscles (P < 0.05; main effect) and in muscles expressing the CnA * transgene compared with WT mice (P < 0.05; Table 1 ). (time = 0 min fatigue), whereas P o of muscles from WT mice never fully recovered (P < 0.05). Uninjured muscles tended to fatigue more than injured/regenerating muscles during the repeated stimulation protocol, but force recovery following the 4 min fatigue protocol tended be superior than injured muscles (N.S.; Fig. 1A ). It should be noted that injured muscle produced less force than uninjured muscles during the fatigue protocol and recovery (Fig. 1B) . Table 2 ). Muscle degeneration, defined as areas of connective tissue, fat, and mononuclear cell infiltration, was assessed at 9 days post-injury. In muscles of MCKCnA * mice, degeneration occupied 38% of the cross-section analyzed, whereas in WT mice it was 51% (P < 0.05; Fig. 2A and 2D) . WT mice, the number of muscle fibers was higher in injured than in uninjured muscle (P < 0.05; Fig. 2 WT mice, such that by 9 days post-injury, myogenin expression was similar in both strains (Fig. 3) . Similarly, the number of myogenin-positive nuclei per muscle fiber (as assessed in cross-section) was lower in the muscles of the MCK-CnA (Fig.   2B ). The proportion of fibers expressing the developmental MyHC isoform was higher in injured than in uninjured muscles (P < 0.05) and similar in regenerating muscles from MCK-CnA * and WT mice (Fig. 5 ).
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DISCUSSION
Calcineurin activation was associated with the upregulation of specific MRFs in regenerating skeletal muscles. Five days post myotoxic injury, myogenin expression was greater and 9 days post-injury, MEF2a levels were greater in muscles from MCK-CnA * mice compared with WT mice. The alterations in MRFs were associated with the enhanced regeneration and maturation of myofibers, since at 9 days post-injury, recovery of fiber size, overall muscle architecture, and relative normalized force producing capacity, were superior in muscles from MCK-CnA * mice than in WT mice.
Calcineurin activation causes a shift to a slower muscle phenotype (22, 29, 47 ) and an increased expression of type IIa and I MyHC isoforms and the slow SERCA2a isoform in skeletal muscle (3, 4) . These effects were associated with concomitant changes in muscle function (46). Similarly, in the present study twitch contraction time (TPT) and relaxation time (½RT) were prolonged in TA muscles of MCK-CnA * compared with WT mice. Consistent with a slower phenotype, muscles from MCK-CnA * mice had an altered twitch:tetanus ratio, fatigued less during repeated contractile activity, and exhibited an improved force recovery. The shift to a slower phenotype reduced the force producing capacity, as evident from the ~20% decrease in P o and ~15% decrease sP o in muscles of MCK-CnA * mice. These changes were attributed to the ~15% decrease in muscle mass and ~30% decrease in fiber size. In TA muscles of MCK-CnA * mice, the decrease in fiber size was two-fold greater than the decrease in muscle mass. This can be accounted for by the 42% increase in myofiber number. In regenerating muscles of MCK-CnA * mice, myofiber number was increased by 28%. We have previously observed a two-fold increase in myofiber number in muscles of CnA We did not detect any deleterious side-effects of calcineurin activation in skeletal muscle. In cardiac muscle, depending on the experimental model, calcineurin activation can either inhibit or enhance apoptosis (27). Cardiomyopathy has been observed in transgenic mice expressing a constitutively active calcineurin transgene (23). Some of these effects have been attributed to mitochondrial dysfunction and elevated superoxide production (39) . Mitochondrial biogenesis is a crucial regulatory event during muscle regeneration. In regenerating rat muscles, the most prominent increase in mitochondrial respiratory capacity occurs between 5 and 9 days post myotoxic injury, presumably to coincide with the increased metabolic cost of regeneration (8) . In our study, differences in regeneration efficacy between MCK-CnA * and WT mice became apparent between 5 and 9 days post injury, making it unlikely that regeneration was compromised by mitochondrial dysfunction or increased reactive oxygen species production. The superior fatigue resistance and increased fatty oxidation capacity of muscles from MCK-CnA * compared to WT mice (37), offer further indirect support for normal mitochondrial function with calcineurin activation in skeletal muscle. Nonetheless, the possibility that calcineurin activation could increase oxidative stress in regenerating skeletal muscles is interesting and worthy of further examination.
In conclusion, activation of the calcineurin signal transduction pathway enhanced regeneration in muscles after myotoxic injury and promoted recovery of force producing capacity. The cellular mechanisms responsible for the improvement in muscle structure and the enhanced recovery of fiber size have yet to be elucidated and may involve alterations in the timing of the MRFs. In addition, any potential side-effects of calcineurin activation need to be assessed carefully (39) . Our findings are consistent with the hypothesis that with calcineurin activation, maturation of regenerating myotubes is more effective. 
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